1) sodium taurocholate
牛黄胆酸钠
1.
(Methods)The SAP model was developed in rats by retrograde injection of 5% sodium taurocholate into biliopancreatic duct through duodenal wall.
方法46只健康雄性SD大鼠分为SAP组和对照组,SAP组经肠壁穿刺逆行胰胆管注射5%牛黄胆酸钠,对照组同法注射等量0。
2.
Objective:To develop an HPLC-ELSD method for simultaneous determination of cholic acid,deoxycholic acid and sodium taurocholate in Niudan powder(from Bos Taurus domesticus Gemelin).
目的:建立HPLC-ELSD同时测定动物类药材牛胆粉中胆酸、去氧胆酸和牛黄胆酸钠3种成分含量的方法。
2) N-((3α,7α,12α)-Trihydroxy-5β-cholan-24-oyl)taurine
牛黄胆酸
3) sodium taurocholate
牛磺胆酸钠
1.
Synthesis and pharmacological effects of sodium taurocholate;
牛磺胆酸钠的合成及其药理作用
2.
Observation on organ’s dysfunction of rats in sodium taurocholate-induced acute necrosis pancreatitis
牛磺胆酸钠诱导的急性坏死性胰腺炎大鼠脏器功能障碍观察
3.
In an acid medium of HCl, H2SO4 or HNO3, bile salts, such as sodium taurocholate, sodium tauroglycocholate, sodium deoxycholate and cow sodium cholate, were able to self-aggregate to form large particles to produce new enhanced resonance Rayleigh scattering (RRS) signals.
研究了牛磺胆酸钠、甘牛胆酸钠、胆酸钠和脱氧胆酸钠等四种胆酸盐在酸性介质中的聚集作用对共振瑞利散射光谱的影响及其分析应用。
4) sodium tauroglycocholate
甘牛胆酸钠
1.
In an acid medium of HCl, H2SO4 or HNO3, bile salts, such as sodium taurocholate, sodium tauroglycocholate, sodium deoxycholate and cow sodium cholate, were able to self-aggregate to form large particles to produce new enhanced resonance Rayleigh scattering (RRS) signals.
研究了牛磺胆酸钠、甘牛胆酸钠、胆酸钠和脱氧胆酸钠等四种胆酸盐在酸性介质中的聚集作用对共振瑞利散射光谱的影响及其分析应用。
5) Sodium taurocholic acid
牛磺胆酸钠
1.
OBJECTIVE To develop a HPLC gradient elution method for the determination of notoginsenoside R1,ginsenoside RG1,ginsenoside Rb1 and sodium taurocholic acid in Pien Tze Huang.
目的建立测定片仔癀中三七皂苷R1、人参皂苷Rg1、人参皂苷Rb1及牛磺胆酸钠的含量。
6) Taurocholic acid sodium salt
牛磺胆酸,甘牛胆酸钠
补充资料：牛黄胆酸
分子式：C26H45NO7S
分子量：515.71
CAS号：81-24-3
性质：非结晶形粉末。 熔点125℃（分解），[α]20/D+38.8°（乙醇-水）。易吸湿。易溶于水，溶于乙醇，几乎不溶于乙醚、乙酸乙酯。遇酸碱分解成胆酸和牛磺酸。
制备方法：由动物器官中提取。
用途：去氢胆酸的中间体。LD50（大鼠）380mg/kg。
分子量：515.71
CAS号：81-24-3
性质：非结晶形粉末。 熔点125℃（分解），[α]20/D+38.8°（乙醇-水）。易吸湿。易溶于水，溶于乙醇，几乎不溶于乙醚、乙酸乙酯。遇酸碱分解成胆酸和牛磺酸。
制备方法：由动物器官中提取。
用途：去氢胆酸的中间体。LD50（大鼠）380mg/kg。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条